Immunic | VTL - Cash And Equivalent


Immunic reported $186.63M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
BioMarin Pharmaceutical USD 2.22B 910.76M Mar/2026
Cipla INR 7.96B 39.9M Sep/2025
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 90.6M 83.14M Dec/2025
CSL USD 2.16B 633M Jun/2025
Enanta Pharmaceuticals USD 37.44M 5.14M Dec/2025
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 186.63M 171.15M Mar/2026
Insmed USD 582.19M 71.74M Mar/2026
Omeros USD 1.9M 2.36M Jun/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Quidel USD 140.4M 29.4M Mar/2026
Ultragenyx Pharmaceutical USD 175M 246M Mar/2026
United Therapeutics USD 1.28B 277.4M Mar/2026
Xoma USD 143.9M 7.68M Jun/2024